The ever-growing perception of cancer stem cells (CSCs) as a plastic state rather than a
hardwired defined entity has evolved our understanding of the functional and biological …

Pancreatic cancer is one of the most aggressive cancers worldwide due to the resistances to
conventional therapies and early metastasis. Recent research has shown that cancer stem …

Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive diseases with a
poor 5-year survival rate. PDAC cells rely on various metabolic pathways to fuel their …

The first discovery of cancer stem cells (CSCs) in leukaemia triggered active research on
stemness in neoplastic tissues. CSCs represent a subpopulation of malignant cells, defined …

Pancreatic cancer (PDAC) is one of the most aggressive solid tumors and is showing
increasing incidence. The aim of our review is to provide practical help for all clinical …

Simple Summary Drug repurposing in combination with clinical standard chemotherapeutics
opens a novel and promising clinical treatment approach for patients with pancreatic cancer …

Pancreatic cancer is one of the most lethal malignant diseases due to its high invasiveness,
early metastatic properties, rapid disease progression, and typically late diagnosis. Notably …

Despite significant progress in medicine, pancreatic cancer is one of the most tardily
diagnosed cancer and is consequently associated with a poor prognosis and a low survival …

Background Umbelliprenin is a sesquiterpene coumarin isolated from Artemisia absinthium
L. and shows antitumor effects in various cancers by inducing apoptosis. However, the …

Cancer still poses a global threat, since a lot of tumors remain untreatable despite all the
available chemotherapeutic drugs, whose side effects, it must also be noted, still raise …